Results from 10 Highly Anticipated Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA20

 

SAN JOSE, Calif., Sept. 9, 2020 /PRNewswire/ -- Leading researchers and physicians will present results from 10 clinical trials that focus on vascular interventional technology and treatment solutions on Friday, November 6, and Saturday, November 7, during the 18th annual VIVA (Vascular InterVentional Advances) conference, which will be held virtually.

The trial results and data will be presented for the first time during VIVA's immersive virtual experience. Media outlets are invited to view the presentations by registering at www.vivaphysicians.org/register20.

Since 2003, VIVA's vascular education symposium has brought together a global, multispecialty faculty to present a variety of talks and live case presentations from clinical centers around the world. Attendees include an international audience of interventional cardiologists, interventional radiologists, vascular surgeons, and endovascular medicine specialists.

To view the conference's full schedule, please visit http://www.vivaphysicians.org/agenda2020. 

Clinical trial results to be released (in order of presentation):

Friday, November 6, beginning at 11:00am PT

5-Year Outcomes from the IN.PACT Global Study
Thomas Zeller, MD, PhD

Drug-Coated Devices & Limb Outcomes After Endovascular Peripheral Artery Revascularizations
Connie Hess, MD, MHS

Standard vs Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism
Efthymios Avgerinos, MD, PhD, MSc

VIVO Study 12-Month Endpoint Results
Anthony Comerota, MD   

PROMISE I 1-Year Results
Daniel Clair, MD     

Saturday, November 7 beginning at 7:00am PT

The DISRUPT PAD III Randomized Controlled Trial
William Gray, MD   

REALITY Study: Directional Atherectomy Vessel Preparation Prior to DCB Angioplasty
Krishna Rocha-Singh, MD          

24-Month Outcomes from the DETOUR 1 Trial for Percutaneous Femoropopliteal Bypass
Ehrin Armstrong, MD

2-Year Outcomes of a Multi-Centre Study on Infrapopliteal Bioresorbable Vascular Scaffold
Steven Kum, MD

4-Year DCB Mortality Across ILLUMENATE RCTs
Sean Lyden, MD    

About VIVA Physicians

VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, strives to be the premier educator in the field. Our team of specialists in vascular medicine, interventional cardiology, interventional radiology, and vascular surgery is driven by the passion to advance the field and improve patient outcomes. Educational events presented by VIVA Physicians have a distinct spirit of collegiality attained by synergizing collective talents to promote awareness and innovative therapeutic options for vascular disease worldwide. To learn more about VIVA Physicians, visit www.vivaphysicians.org.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/results-from-10-highly-anticipated-vascular-interventional-clinical-trials-to-be-presented-for-the-first-time-at-viva20-301126857.html

SOURCE VIVA Physicians

 

Back to news